Baumgartner, R.; Casagrande, F.B.; Mikkelsen, R.B.; Berg, M.; Polyzos, K.A.; Forteza, M.J.; Arora, A.; Schwartz, T.W.; Hjorth, S.A.; Ketelhuth, D.F.J.
Disruption of GPR35 Signaling in Bone Marrow-Derived Cells Does Not Influence Vascular Inflammation and Atherosclerosis in Hyperlipidemic Mice. Metabolites 2021, 11, 411.
https://doi.org/10.3390/metabo11070411
AMA Style
Baumgartner R, Casagrande FB, Mikkelsen RB, Berg M, Polyzos KA, Forteza MJ, Arora A, Schwartz TW, Hjorth SA, Ketelhuth DFJ.
Disruption of GPR35 Signaling in Bone Marrow-Derived Cells Does Not Influence Vascular Inflammation and Atherosclerosis in Hyperlipidemic Mice. Metabolites. 2021; 11(7):411.
https://doi.org/10.3390/metabo11070411
Chicago/Turabian Style
Baumgartner, Roland, Felipe B. Casagrande, Randi B. Mikkelsen, Martin Berg, Konstantinos A. Polyzos, Maria J. Forteza, Aastha Arora, Thue W. Schwartz, Siv A. Hjorth, and Daniel F. J. Ketelhuth.
2021. "Disruption of GPR35 Signaling in Bone Marrow-Derived Cells Does Not Influence Vascular Inflammation and Atherosclerosis in Hyperlipidemic Mice" Metabolites 11, no. 7: 411.
https://doi.org/10.3390/metabo11070411
APA Style
Baumgartner, R., Casagrande, F. B., Mikkelsen, R. B., Berg, M., Polyzos, K. A., Forteza, M. J., Arora, A., Schwartz, T. W., Hjorth, S. A., & Ketelhuth, D. F. J.
(2021). Disruption of GPR35 Signaling in Bone Marrow-Derived Cells Does Not Influence Vascular Inflammation and Atherosclerosis in Hyperlipidemic Mice. Metabolites, 11(7), 411.
https://doi.org/10.3390/metabo11070411
